| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/02/2000 | EP0975333A1 Sustained-release alginate gels |
| 02/02/2000 | EP0975330A1 Pain reducing parenteral liposome formulation |
| 02/02/2000 | EP0975329A1 Lipid complexes and liposomes of highly insoluble platinum complexes |
| 02/02/2000 | EP0975328A1 Method for oral delivery of proteins |
| 02/02/2000 | EP0975326A1 Topical application of enzymes using a peelable film |
| 02/02/2000 | EP0975227A1 Topical use of probiotic bacillus spores to prevent or control microbial infections |
| 02/02/2000 | EP0975216A1 A method for treating papillomavirus infections |
| 02/02/2000 | EP0881891A4 Male contraceptive implant |
| 02/02/2000 | CN1243460A Film coatings and film coating compositions based on dextrin |
| 02/02/2000 | CN1243438A Pharmaceutical composition of fenofibrate with high biological utilizing rate |
| 02/02/2000 | CN1243437A Use of dichlorobenzyl alchol for preparing a preparation for topical treatment of inflammation and preparation containing dichlorobenzyl alchol |
| 02/02/2000 | CN1242984A 4,4-diaryl butadienes compound as water soluble non-photosensitive ultraviolet-ray filtering agent used in cosmetics and medicinal preparation |
| 02/01/2000 | US6020384 Solid oral unit dosage form; therapy of liver disorders |
| 02/01/2000 | US6020359 Injectable solution of 3-(2-(phenylcarbamoyl)ethenyl)-4,6-dichloroindole-2-carboxylic acid; glycine antagonist |
| 02/01/2000 | US6020341 Enediyne quinone imines and methods of preparation and use thereof |
| 02/01/2000 | US6020326 Method for inhibition of bone growth by anionic polymers |
| 02/01/2000 | US6020317 Glycerol derivative, device and pharmaceutical composition |
| 02/01/2000 | US6020315 Preparation having increased in vivo tolerability |
| 02/01/2000 | US6020200 Encapsulation compositions and methods |
| 02/01/2000 | US6020167 Composition used as a therapeutic agent against chronic viral hepatic diseases |
| 02/01/2000 | US6020145 Methods for determining the presence of carcinoma using the antigen binding region of monoclonal antibody BR96 |
| 02/01/2000 | US6020144 These organisms have evolved a sophisticated ability to infect a host and evade their host's immune defenses. |
| 02/01/2000 | US6020142 Rath genes and polypeptides and methods for the treatment and diagnosis of immune disorders |
| 02/01/2000 | US6020001 Compositions for treating migraine |
| 02/01/2000 | US6019997 Includes a lower alcohol and water in a weight ratio of at least about 20:80, a pharmaceutical agent, and an emulsifier system |
| 02/01/2000 | US6019983 Gnrh peptide conjugate to e. coli fimbrial-filaments and elicits an immune response against gnrh. |
| 02/01/2000 | US6019970 Treatment of iodine deficiency diseases |
| 02/01/2000 | CA2173387C A process for the preparation of a liposomal, in water dispersive, orally administerable, solid, dry therapeutic formulation |
| 02/01/2000 | CA2161191C Product containing a lipase and an active precursor for topical application |
| 02/01/2000 | CA1340887C Sialic acid glycosides, antigens, immunoadsorbents, and methods for thier preparation |
| 01/30/2000 | CA2279121A1 Dermatological, pharmaceutical or cosmetic patch |
| 01/27/2000 | WO2000004052A2 Soluble derivatives of anti-angiogenic peptides |
| 01/27/2000 | WO2000003980A1 5-THIA-φ-SUBSTITUTED PHENYL-PROSTAGLANDIN E DERIVATIVES, PROCESS FOR PRODUCING THE SAME AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT |
| 01/27/2000 | WO2000003753A2 Microdisperse drug delivery systems |
| 01/27/2000 | WO2000003744A2 Adjuvant and vaccine compositions containing monophosphoryl lipid a |
| 01/27/2000 | WO2000003737A2 Water-soluble drugs and methods for their production |
| 01/27/2000 | WO2000003735A1 Excipient |
| 01/27/2000 | WO2000003733A1 Methods and compositions for cancer treatment |
| 01/27/2000 | WO2000003724A1 Preparations for immunotherapy for cancer having bacterial somatic constituent as the active ingredient |
| 01/27/2000 | WO2000003698A1 Transdermal patch and topical compositions comprising propylnorapomorphine |
| 01/27/2000 | WO2000003697A1 Pellets having a core coated with an antifungal and a polymer |
| 01/27/2000 | WO2000003696A1 Enteric coated pharmaceutical tablet and method of manufacturing |
| 01/27/2000 | WO2000003695A1 Pharmaceutical suspension formulation comprising amoxycillin, clavulanic acid and cellulose |
| 01/27/2000 | WO2000003694A1 Charge reversal of polyion complexes |
| 01/27/2000 | WO2000003683A2 Liposomal encapsulated nucleic acid-complexes |
| 01/27/2000 | WO2000003680A2 Emollient esters based upon capryl alcohol and isostearic acid |
| 01/27/2000 | WO2000003609A1 Coloration with pearly luster pigments in the food and pharmaceutical sectors |
| 01/27/2000 | WO1999063930A3 Novel angiotensin receptor modulators and their uses |
| 01/27/2000 | WO1999062503A3 Use of indigoid bisindole derivatives for the manufacture of a medicament to inhibit cyclin dependent kinases |
| 01/27/2000 | WO1999057094A3 Perfluorinated esters of alkanoyl l-carnitine for the preparation of cationic lipids for the intracellular delivery of pharmacologically active compounds |
| 01/27/2000 | WO1999050303A3 Immune response modulator alpha-2 macroglobulin complex |
| 01/27/2000 | WO1999017780A8 Dexamethasone gel |
| 01/27/2000 | DE19918435A1 Coating or binding agent for medicaments, prepared using finely divided acrylic copolymer powder, used e.g. for taste-masking coatings or in transdermal delivery systems |
| 01/27/2000 | DE19833287A1 Production of crosslinked cationic polymers in powder form, e.g. useful as cosmetic or pharmaceutical additives, comprises polymerization in supercritical carbon dioxide |
| 01/27/2000 | DE19833119A1 Storage-stable injectable solution of vasodilator and beta blocker Carvedilol contains buffer, organic solvent, antioxidant and complexing agent |
| 01/27/2000 | CA2631050A1 Procedures for obtaining polymers derived from vinyl acetate and their use |
| 01/27/2000 | CA2337516A1 Transdermal patch and topical compositions comprising propylnorapomorphine |
| 01/27/2000 | CA2337445A1 Preparations for immunotherapy for cancer having bacterial somatic constituent as the active ingredient |
| 01/27/2000 | CA2333929A1 Soluble derivatives of anti-angiogenic peptides |
| 01/27/2000 | CA2302735A1 Microdisperse drug delivery systems |
| 01/26/2000 | EP0974366A1 Oral pharmaceutical preparations decreased in bitterness by masking |
| 01/26/2000 | EP0974365A1 Use of an acrylic-type polymer as desintregrating agent |
| 01/26/2000 | EP0974364A1 Method of inhibiting drug precipitation |
| 01/26/2000 | EP0974359A2 FSH and FSH variant formulations, products and methods |
| 01/26/2000 | EP0974350A1 External preparation containing tranilast and process for producing the same |
| 01/26/2000 | EP0974344A2 Composition and pharmaceutical dosage form for colonic drug delivery using polysaccharides |
| 01/26/2000 | EP0973886A2 METHOD AND CONJUGATE FOR TREATING $i(H. PYLORI) INFECTION |
| 01/26/2000 | EP0973819A1 Non-antigenic branched polymer conjugates |
| 01/26/2000 | EP0973818A1 Biodegradable terephthalate polyester-poly(phosphate) polymers, compositions, articles, and methods for making and using the same |
| 01/26/2000 | EP0973806A1 Site protected protein modification |
| 01/26/2000 | EP0973785A1 Trans-platinum compound, and diagnostic kit |
| 01/26/2000 | EP0973710A2 Omega-amino acid derivatives, processes of their preparation and their use |
| 01/26/2000 | EP0973575A1 Gene therapeutic treatment of blood vessel associated disorders |
| 01/26/2000 | EP0973559A1 Method and composition for coating wound or protecting animal skin |
| 01/26/2000 | EP0973552A2 Improvements in or relating to diagnostic/therapeutic agents |
| 01/26/2000 | EP0973551A2 Polymeric conjugates polyvalently presenting an agent for therapy |
| 01/26/2000 | EP0973546A2 Stabilized human papillomavirus formulations |
| 01/26/2000 | EP0973527A1 Extended release formulations of erythromycin derivatives |
| 01/26/2000 | EP0973525A1 Oral compositions containing fluocinonide |
| 01/26/2000 | EP0973522A1 Topical gel composition containing a combination of a nsaid and a xanthine derivative |
| 01/26/2000 | EP0973520A1 Granules comprising clavulanate and one or more excipients |
| 01/26/2000 | EP0973519A1 Inclusion complexes in aqueous solution |
| 01/26/2000 | EP0973507A1 Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same |
| 01/26/2000 | EP0973505A1 Aqueous pharmaceutical composition comprising an active ingredient which is highly insoluble in water |
| 01/26/2000 | EP0973502A1 Lipophilic binary systems for the administration of lipophilic compounds |
| 01/26/2000 | EP0973501A2 Aqueous suspension for nasal administration of loteprednol |
| 01/26/2000 | EP0973499A1 Diffusional implantable delivery system |
| 01/26/2000 | EP0841854A4 Novel compositions for use in embolizing blood vessels |
| 01/26/2000 | EP0758895B1 Sublingual dosage forms containing apomorphine for use in the treatment of erectile dysfunction |
| 01/26/2000 | EP0722316B1 New emulsion formulation |
| 01/26/2000 | EP0695173B1 Manufacturing matrices |
| 01/26/2000 | CN1242708A Conjugates useful in treatment of prostate cancer |
| 01/26/2000 | CN1242705A Granules comprising clavulanate and one or more excipients |
| 01/26/2000 | CN1242704A Tabletted prepn. |
| 01/26/2000 | CN1242702A Method and compositions for improved bioavailability of bioactive agent for mucosal delivery |
| 01/26/2000 | CN1048627C Medicinal aerosol prepn. |
| 01/25/2000 | US6018080 Atovaquone pharmaceutical compositions |
| 01/25/2000 | US6018019 Immunogenic synthetic peptides which are useful alone or in conjugates in vaccines against hemophilus influenza infection |
| 01/25/2000 | US6018009 Polymer support in particle form comprising isocyanate groups dispersed on a crosslinked polymeric backbone; high surface area for covalently binding proteins such as enzymes; insoluble in both aqueous and organic media |
| 01/25/2000 | US6017966 Stabilized pharmaceutical compositions containing dobutamine |